Novo Nordisk Pharmaceutical Industries, Inc. NNPII NNPII
 
Send to a friendPrint

Novo Nordisk A/S



Novo Nordisk Pharmaceutical Industries, Inc. (NNPII) in Clayton, NC is a manufacturing unit within Novo Nordisk A/S. Headquartered in Denmark and represented in 76 countries on five continents, Novo Nordisk A/S employs over 31,000 people worldwide. Production sites include:  Denmark, France, China, Japan, Brazil and the United States.  We are number 1 in the world in diabetes sales and volume.

Novo Nordisk A/S is a focused healthcare company. With the broadest diabetes product portfolio in the industry, we are a world leader in diabetes care. In addition, Novo Nordisk A/S has a leading position within haemostasis management, growth disorders and hormone replacement therapy.

Our production is based on biotechnology; fermentation is the basis of our pharmaceuticals, using genetically modified microorganisms.

We market our products in 179 countries.
 

 
 

Learn more about the history of Novo Nordisk A/S.